eyes
-
Valeant to Buy Bausch & Lomb for $8.7 Billion
[THE NEW YORK TIMES] Bausch & Lomb, the eye care company, agreed on Monday to sell itself to Valeant Pharmaceuticals International of…
Read More »
[THE NEW YORK TIMES] Bausch & Lomb, the eye care company, agreed on Monday to sell itself to Valeant Pharmaceuticals International of…
Read More »
A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.
